TrialJournal of cancer research and clinical oncology2024

A prospective randomized controlled clinical trial investigating the efficacy of low-dose olanzapine in preventing nausea and vomiting associated with oxaliplatin-based and irinotecan-based chemotherapy.

Jing Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.